<?xml version="1.0" ?>
<document id="30071673">
  <sentence id="30071673.s0" text="&lt;i&gt;vascular endothelial growth factor receptor signaling pathway&lt;/i&gt;, which is a gene encoding the ligand for the vascular endothelial growth factor receptor 3 (negative regulation of transcription by RNA polymerase IIR3/FLT4) and important for lymph vessel development during lymphangiogenesis, has been associated with a specific subtype of primary lymphedema.">
    <entity charOffset="3-64" id="30071673.s0.e0" ontology_id="GO_0048010" text="vascular endothelial growth factor receptor signaling pathway" type="GO"/>
    <entity charOffset="161-218" id="30071673.s0.e1" ontology_id="GO_0000122" text="negative regulation of transcription by RNA polymerase II" type="GO"/>
    <entity charOffset="356-361" id="30071673.s0.e2" ontology_id="HP_0000969" text="edema" type="HP"/>
    <pair e1="30071673.s0.e0" e2="30071673.s0.e2" id="30071673.s0.p0" relation="true"/>
    <pair e1="30071673.s0.e1" e2="30071673.s0.e2" id="30071673.s0.p1" relation="false"/>
  </sentence>
  <sentence id="30071673.s1" text="Through Sanger sequencing of a proband with bilateral congenital pedal edema resembling Milroy disease, we identified a novel mutation (NM_005429.2; c.361+5G&amp;gt;A) in &lt;i&gt;vascular endothelial growth factor receptor signaling pathway&lt;/i&gt;.">
    <entity charOffset="44-53" id="30071673.s1.e0" ontology_id="HP_0012832" text="bilateral" type="HP"/>
    <entity charOffset="71-76" id="30071673.s1.e1" ontology_id="HP_0000969" text="edema" type="HP"/>
    <entity charOffset="170-231" id="30071673.s1.e2" ontology_id="GO_0048010" text="vascular endothelial growth factor receptor signaling pathway" type="GO"/>
    <pair e1="30071673.s1.e0" e2="30071673.s1.e2" id="30071673.s1.p0" relation="false"/>
    <pair e1="30071673.s1.e1" e2="30071673.s1.e2" id="30071673.s1.p1" relation="true"/>
  </sentence>
</document>
